STRIDE INC (LRN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:LRN • US86333M1080

86.375 USD
-0.08 (-0.09%)
Last: Feb 5, 2026, 03:00 PM
Fundamental Rating

7

Taking everything into account, LRN scores 7 out of 10 in our fundamental rating. LRN was compared to 76 industry peers in the Diversified Consumer Services industry. Both the health and profitability get an excellent rating, making LRN a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on LRN. This makes LRN very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year LRN was profitable.
  • In the past year LRN had a positive cash flow from operations.
  • LRN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years LRN had a positive operating cash flow.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • LRN has a better Return On Assets (13.83%) than 88.16% of its industry peers.
  • With an excellent Return On Equity value of 20.61%, LRN belongs to the best of the industry, outperforming 85.53% of the companies in the same industry.
  • LRN's Return On Invested Capital of 16.82% is amongst the best of the industry. LRN outperforms 93.42% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LRN is in line with the industry average of 10.27%.
  • The 3 year average ROIC (11.97%) for LRN is below the current ROIC(16.82%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROIC 16.82%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of LRN (12.66%) is better than 77.63% of its industry peers.
  • LRN's Profit Margin has improved in the last couple of years.
  • LRN has a Operating Margin of 18.38%. This is amongst the best in the industry. LRN outperforms 80.26% of its industry peers.
  • In the last couple of years the Operating Margin of LRN has grown nicely.
  • With a Gross Margin value of 39.30%, LRN perfoms like the industry average, outperforming 44.74% of the companies in the same industry.
  • LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • LRN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for LRN has been increased compared to 1 year ago.
  • Compared to 5 years ago, LRN has more shares outstanding
  • Compared to 1 year ago, LRN has an improved debt to assets ratio.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • LRN has an Altman-Z score of 6.09. This indicates that LRN is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of LRN (6.09) is better than 93.42% of its industry peers.
  • LRN has a debt to FCF ratio of 3.02. This is a good value and a sign of high solvency as LRN would need 3.02 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 3.02, LRN is doing good in the industry, outperforming 76.32% of the companies in the same industry.
  • LRN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • LRN has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Altman-Z 6.09
ROIC/WACC2.08
WACC8.07%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • LRN has a Current Ratio of 7.27. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
  • LRN's Current ratio of 7.27 is amongst the best of the industry. LRN outperforms 97.37% of its industry peers.
  • A Quick Ratio of 7.19 indicates that LRN has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 7.19, LRN belongs to the top of the industry, outperforming 97.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.27
Quick Ratio 7.19
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.03% over the past year.
  • Measured over the past years, LRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 58.07% on average per year.
  • The Revenue has grown by 14.86% in the past year. This is quite good.
  • Measured over the past years, LRN shows a quite strong growth in Revenue. The Revenue has been growing by 18.24% on average per year.
EPS 1Y (TTM)16.03%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%23.15%
Revenue 1Y (TTM)14.86%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%7.5%

3.2 Future

  • LRN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.94% yearly.
  • LRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.21% yearly.
EPS Next Y20.97%
EPS Next 2Y13.66%
EPS Next 3Y11.94%
EPS Next 5YN/A
Revenue Next Year6.21%
Revenue Next 2Y5.8%
Revenue Next 3Y5.91%
Revenue Next 5Y4.21%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • LRN is valuated correctly with a Price/Earnings ratio of 12.43.
  • 81.58% of the companies in the same industry are more expensive than LRN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 28.25. LRN is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 11.11 indicates a reasonable valuation of LRN.
  • 84.21% of the companies in the same industry are more expensive than LRN, based on the Price/Forward Earnings ratio.
  • LRN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 12.43
Fwd PE 11.11
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 78.95% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 68.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.11
EV/EBITDA 6.15
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of LRN may justify a higher PE ratio.
PEG (NY)0.59
PEG (5Y)0.21
EPS Next 2Y13.66%
EPS Next 3Y11.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for LRN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STRIDE INC

NYSE:LRN (2/5/2026, 3:00:04 PM)

86.375

-0.08 (-0.09%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-27
Earnings (Next)04-27
Inst Owners111.2%
Inst Owner Change-0.92%
Ins Owners3.06%
Ins Owner Change2.44%
Market Cap3.79B
Revenue(TTM)2.52B
Net Income(TTM)318.94M
Analysts82
Price Target131.71 (52.49%)
Short Float %14.64%
Short Ratio4.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.44%
Min EPS beat(2)18.86%
Max EPS beat(2)26.01%
EPS beat(4)2
Avg EPS beat(4)0.71%
Min EPS beat(4)-41.53%
Max EPS beat(4)26.01%
EPS beat(8)6
Avg EPS beat(8)44.91%
EPS beat(12)10
Avg EPS beat(12)45.21%
EPS beat(16)13
Avg EPS beat(16)17.55%
Revenue beat(2)1
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.46%
Max Revenue beat(2)0.16%
Revenue beat(4)3
Avg Revenue beat(4)1.49%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.34%
Revenue beat(8)7
Avg Revenue beat(8)2.32%
Revenue beat(12)10
Avg Revenue beat(12)2.47%
Revenue beat(16)14
Avg Revenue beat(16)2.55%
PT rev (1m)-0.92%
PT rev (3m)-25.72%
EPS NQ rev (1m)3.47%
EPS NQ rev (3m)-15.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.71%
Revenue NQ rev (1m)0.93%
Revenue NQ rev (3m)-8.25%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-5.93%
Valuation
Industry RankSector Rank
PE 12.43
Fwd PE 11.11
P/S 1.5
P/FCF 21.11
P/OCF 15.31
P/B 2.45
P/tB 3.3
EV/EBITDA 6.15
EPS(TTM)6.95
EY8.05%
EPS(NY)7.78
Fwd EY9%
FCF(TTM)4.09
FCFY4.74%
OCF(TTM)5.64
OCFY6.53%
SpS57.44
BVpS35.29
TBVpS26.14
PEG (NY)0.59
PEG (5Y)0.21
Graham Number74.29
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROCE 22.19%
ROIC 16.82%
ROICexc 24.03%
ROICexgc 33.13%
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
FCFM 7.12%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexgc growth 3Y30.19%
ROICexgc growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Debt/EBITDA 0.83
Cap/Depr 57.06%
Cap/Sales 2.7%
Interest Coverage 44.37
Cash Conversion 42.51%
Profit Quality 56.26%
Current Ratio 7.27
Quick Ratio 7.19
Altman-Z 6.09
F-Score7
WACC8.07%
ROIC/WACC2.08
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)16.03%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%23.15%
EPS Next Y20.97%
EPS Next 2Y13.66%
EPS Next 3Y11.94%
EPS Next 5YN/A
Revenue 1Y (TTM)14.86%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%7.5%
Revenue Next Year6.21%
Revenue Next 2Y5.8%
Revenue Next 3Y5.91%
Revenue Next 5Y4.21%
EBIT growth 1Y38.43%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year36%
EBIT Next 3Y15.81%
EBIT Next 5Y18.08%
FCF growth 1Y13.3%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y12.51%
OCF growth 3Y27.9%
OCF growth 5Y40.03%

STRIDE INC / LRN FAQ

What is the ChartMill fundamental rating of STRIDE INC (LRN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LRN.


What is the valuation status of STRIDE INC (LRN) stock?

ChartMill assigns a valuation rating of 8 / 10 to STRIDE INC (LRN). This can be considered as Undervalued.


How profitable is STRIDE INC (LRN) stock?

STRIDE INC (LRN) has a profitability rating of 8 / 10.


What is the expected EPS growth for STRIDE INC (LRN) stock?

The Earnings per Share (EPS) of STRIDE INC (LRN) is expected to grow by 20.97% in the next year.


Can you provide the dividend sustainability for LRN stock?

The dividend rating of STRIDE INC (LRN) is 0 / 10 and the dividend payout ratio is 0%.